We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Serum TGF-β, Serum MMP-1, and HOMA-IR as Non-Invasive Predictors of Fibrosis in Egyptian Patients with NAFLD.
- Authors
Mahmoud, Adel A.; Bakir, Amal S.; Shabana, Sherif S.
- Abstract
Background/Aim: Non-alcoholic fatty liver disease (NAFLD) is an increasingly prevalent cause of chronic liver disease worldwide. A number of these patients progress to nonalcoholic steatohepatitis (NASH) which carries significant morbidity and mortality. The aim of this study is to evaluate the diagnostic value of serum levels of transforming growth factor beta-1 (TGF-β1) matrix metalloproteinase-1 (MMP-1), and insulin resistance as predictors of fibrosis in Egyptian NAFLD patients. Patients and Methods: Fifty patients with NAFLD and different stages of fibrosis were studied. Serum levels of TGF-β1, MMP-1, and fasting serum insulin were measured; calculation of the homeostasis model assessment for insulin resistance (HOMA-IR) was done. Results: TGF-β1 gives a sensitivity of 100% and specificity of 94.4% for stage 1 fibrosis, 100% and 93.9%, respectively, for stage 2 fibrosis, and 97.7% and 100%, respectively, for stage 3 fibrosis. MMP-1 showed sensitivity and specificity of 88% and 81.8%, respectively, for stage 2 fibrosis, 90.9% and 55.56%, respectively, for stage 3 fibrosis, but it is of no diagnostic value in stage 1 fibrosis. Conclusion: Serum TGF-β1, MMP-1, and insulin resistance (HOMA-IR) proved to be potentially useful noninvasive markers in predicting fibrosis in NASH patients.
- Subjects
EGYPT; BIOMARKERS; BIOPSY; STATISTICAL correlation; ENZYME-linked immunosorbent assay; FATTY liver; GROWTH factors; INSULIN resistance; MULTIVARIATE analysis; PROTEOLYTIC enzymes; FIBROSIS; RECEIVER operating characteristic curves; DATA analysis software
- Publication
Saudi Journal of Gastroenterology, 2012, Vol 18, Issue 5, p327
- ISSN
1319-3767
- Publication type
Article
- DOI
10.4103/1319-3767.101132